Cowen and Company’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

Cowen and Company’s Portfolio LUXAW Stock Details LUXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-573,002	Closed	-$74K	–	881
2022 Q3	$74K	Sell	573,002 -135,406	-19%	-$19.2K	0.01%	241
2022 Q2	$106K	Buy	708,408 +10,314	+1%	+$2.59K	0.01%	238
2022 Q1	$293K	Buy	+698,094	New	+$397K	0.03%	199
2021 Q4	–	Sell	-18,282	Closed	-$21K	–	860
2021 Q3	$21K	Buy	+18,282	New	+$21.1K	﹤0.01%	484
2021 Q2	–	Sell	-23,657	Closed	-$35K	–	797
2021 Q1	$35K	Buy	+23,657	New	+$59.6K	﹤0.01%	417

Cowen and Company's LUXAW Position: Q4 2022 in Review

Cowen and Company sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q4 2022, closing a stake of 573,002 shares — an estimated $74K sold.

Cowen and Company first reported a position in LUXAW in Q1 2021 and held it in 5 quarters. The position peaked at $293K in Q1 2022. 0 funds tracked by Wall St. Rank hold LUXAW as of Q4 2022.

Cowen and Company reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
Cowen and Company sold 573,002 Lux Health Tech Acquisition Corp. Warrants shares in Q4 2022, an estimated $74K.
Cowen and Company first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q1 2021 and held it in 5 quarters.
Cowen and Company's Lux Health Tech Acquisition Corp. Warrants position peaked at $293K in Q1 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.